Cargando…

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ

PURPOSE: To examine the associations between sentinel lymph node biopsy (SLNB) and complications among older patients who underwent breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). METHODS: We identified women from the Surveillance, Epidemiology, and End Results–Medicare dataset...

Descripción completa

Detalles Bibliográficos
Autores principales:	Killelea, Brigid K., Long, Jessica B., Dang, Weixiong, Mougalian, Sarah S., Evans, Suzanne B., Gross, Cary P., Wang, Shi-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Breast Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928184/ https://www.ncbi.nlm.nih.gov/pubmed/29516364 http://dx.doi.org/10.1245/s10434-018-6410-0

Ejemplares similares

Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Hung, Peiyin, et al.
Publicado: (2019)

Ductal Carcinoma In Situ and Sentinel Lymph Node Biopsy
por: Son, Bok Kyoung, et al.
Publicado: (2011)

A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection
por: Kootstra, Jan J., et al.
Publicado: (2010)

Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?
por: Tuttle, Todd M., et al.
Publicado: (2021)

Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management
por: Qiu, Peng-Fei, et al.
Publicado: (2019)

Sentinel Lymph Node Mapping and Biopsy in Breast Cancer Patients During the COVID-19 Pandemic
por: Cocco, Daniela, et al.
Publicado: (2021)

The Use of Wearable Activity Monitors to Measure Upper Limb Physical Activity After Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy
por: Che Bakri, Nur Amalina, et al.
Publicado: (2023)

Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer
por: Li, Peiyong, et al.
Publicado: (2023)

De-escalation of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ
por: Abdulla, Hussain A, et al.
Publicado: (2023)

RE: Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Meurs, Claudia J C, et al.
Publicado: (2020)

Surgeons’ preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study
por: Karakatsanis, Andreas, et al.
Publicado: (2023)

Quality of Life After Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection in Stage I/II Breast Cancer Patients: A Prospective Longitudinal Study
por: Kootstra, Jan, et al.
Publicado: (2008)

The Lymphatic Anatomy of the Breast and its Implications for Sentinel Lymph Node Biopsy: A Human Cadaver Study
por: Suami, Hiroo, et al.
Publicado: (2007)

Intramammary Sentinel Lymph Nodes: What is the Clinical Significance?
por: Cox, Charles E., et al.
Publicado: (2008)

Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
por: Damle, Sameer, et al.
Publicado: (2009)

Sentinel Node Biopsy in Ductal Carcinoma in Situ: Is it Justifiable?
por: Al-Shurbasi, Nour, et al.
Publicado: (2021)

Postdischarge Nonsteroidal Anti-Inflammatory Drugs Are not Associated with Risk of Hematoma after Lumpectomy and Sentinel Lymph Node Biopsy with Multimodal Analgesia
por: Pawloski, Kate R., et al.
Publicado: (2021)

The Microanatomic Location of Metastatic Breast Cancer in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node Involvement
por: van Deurzen, Carolien H. M., et al.
Publicado: (2008)

Risk of Regional Recurrence After Negative Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence
por: Poodt, Ingrid G. M., et al.
Publicado: (2018)

Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
por: Zavagno, Giorgio, et al.
Publicado: (2005)

Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis
por: Shin, Young Duck, et al.
Publicado: (2021)

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Axillary Recurrence After a Tumor-Positive Sentinel Lymph Node Biopsy Without Axillary Treatment: A Review of the Literature
por: Francissen, Claire M. T. P., et al.
Publicado: (2012)

Percutaneous Sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer
por: Hao, Yunxia, et al.
Publicado: (2021)

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
por: Ling, Diane C., et al.
Publicado: (2019)

The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study
por: Tunon-de-Lara, Christine, et al.
Publicado: (2015)

Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial
por: Nguyen, Chu Luan, et al.
Publicado: (2023)

Extracapsular Invasion of Sentinel Lymph Nodes Is Not Associated With Disease Recurrence in Breast Cancer
por: Fujii, Takaaki, et al.
Publicado: (2014)

Sentinel Lymph Node Biopsy Should Be Included with the Initial Surgery for High-Risk Ductal Carcinoma-In-Situ
por: Tan, Ern Yu, et al.
Publicado: (2014)

Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital
por: Sá, Rafael da Silva, et al.
Publicado: (2021)

Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
por: Tada, Keiichiro, et al.
Publicado: (2010)

A nomogram constructed using intraoperative ex vivo shear-wave elastography precisely predicts metastasis of sentinel lymph nodes in breast cancer
por: Bae, Soong June, et al.
Publicado: (2019)

Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy
por: Unkart, Jonathan T., et al.
Publicado: (2015)

Response to Meurs, Menke-Pluijmers, Seisling, and Westenend
por: Wang, Shi-Yi, et al.
Publicado: (2020)

Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer
por: van Roozendaal, Lori M., et al.
Publicado: (2015)

Prediction of Sentinel Lymph Node Metastasis in Breast Ductal Carcinoma In Situ Diagnosed by Preoperative Core Needle Biopsy
por: Zhang, Kai, et al.
Publicado: (2020)

Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal
por: Cebrecos, Isaac, et al.
Publicado: (2023)

Discordance of Intraoperative Frozen Section Analysis with Definitive Histology of Sentinel Lymph Nodes in Breast Cancer Surgery: Complementary Axillary Lymph Node Dissection is Irrelevant for Subsequent Systemic Therapy
por: Geertsema, D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4h3bp26ioc4g47ln0f0ib1l9hv